← back to search

Timothy J. Yeatman

University of South Florida · US
Area of research
Oncology · Cancer Research
Research interest
Research interests include Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, and Gene expression and cancer classification.
h-index
65
citations
19,518
works
300
NIH funding
primary concept
Medicine
email

Recent publications

Evaluation of cell-free DNA approaches for multi-cancer early detection
Cancer Cell 2022cited by 307position: middledoi
An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy
BMC Cancer 2022cited by 20position: lastdoi
Additional file 3 of Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m6A-dependent stabilization of TCF7L2 mRNA and colorectal cancer progression
Open MIND 2022cited by 0position: middledoi
APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes
Cancers 2021cited by 22position: lastdoi
Impact of Rurality on Melanoma Diagnosis in Utah
Melanoma Management 2021cited by 10position: middledoi
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
Annals of Oncology 2020cited by 1,482position: middledoi
lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
Nature Medicine 2017cited by 452position: middledoi
Three-dimensional culture system identifies a new mode of cetuximab resistance and disease-relevant genes in colorectal cancer
Proceedings of the National Academy of Sciences 2017cited by 45position: middledoi
Phase II study of first-line radioembolization with yttrium-90 glass microspheres for intrahepatic cholangiocarcinoma.
Journal of Clinical Oncology 2017cited by 2position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mingli Yang · Zunyi Medical University3 papers (2017–2022)Yuanyuan Lu · China Pharmaceutical University2 papers (2017–2017)Ramya Thota · Creighton University2 papers (2021–2022) · 2 papers (2017–2017)Robert J. Coffey · Vanderbilt University2 papers (2017–2017)Cunxi Li · Xiamen University2 papers (2017–2017)Michael J. Schell · Moffitt Cancer Center2 papers (2021–2022)Lance Pflieger · Buck Institute for Research on Aging2 papers (2021–2022)Huaying Hu · Xiamen University2 papers (2017–2017)Heiman Wang · University of South Florida2 papers (2021–2022)Bhuminder Singh · Iowa State University2 papers (2017–2017)Thomas B. Davis · University of Utah2 papers (2021–2022)W. J. Pledger · University of South Florida2 papers (2021–2022)Carol Sweeney · Centre for Cancer Biology1 papers (2021–2021)William Fry · University of California, Davis1 papers (2017–2017)William T. Sause · Intermountain Healthcare1 papers (2021–2021)Binglin Yue · University of South Florida1 papers (2017–2017)Christine H. Chung · Diabetes & Endocrine Associates1 papers (2017–2017)Malini Rajan · Arrien Pharmaceuticals (United States)1 papers (2021–2021)Jeffrey L. Franklin · University of Notre Dame1 papers (2017–2017)